id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-0271-0007,FDA,FDA-2014-E-0271,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2016-08-01T04:00:00Z,2016,8,2016-08-01T04:00:00Z,,2016-08-02T02:56:16Z,,0,0,090000648214b3e9
FDA-2014-E-0271-0006,FDA,FDA-2014-E-0271,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ARGUS II VISUAL STIMULATION SYSTEM",Notice,Determinations,2015-12-10T05:00:00Z,2015,12,2015-12-10T05:00:00Z,2016-02-09T04:59:59Z,2015-12-10T17:09:17Z,2015-31095,0,0,0900006481d9ac0b
FDA-2014-E-0271-0005,FDA,FDA-2014-E-0271,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-09T05:00:00Z,2015,11,2015-11-09T05:00:00Z,,2015-11-09T14:02:20Z,,0,0,0900006481d2728f
FDA-2014-E-0271-0004,FDA,FDA-2014-E-0271,Letter from the U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-03-25T04:00:00Z,2015,3,2015-03-25T04:00:00Z,,2015-03-25T15:26:29Z,,0,0,0900006481a63eaa
FDA-2014-E-0271-0003,FDA,FDA-2014-E-0271,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2014-05-27T04:00:00Z,2014,5,2014-05-27T04:00:00Z,,2014-05-27T12:55:39Z,,0,0,0900006481715539
FDA-2014-E-0271-0001,FDA,FDA-2014-E-0271,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T13:06:02Z,,0,0,09000064815fd1b3
FDA-2014-E-0271-0002,FDA,FDA-2014-E-0271,"Patent Extension from Second Sight Medical Products, Inc.",Other,Application,2014-03-06T05:00:00Z,2014,3,2014-03-06T05:00:00Z,,2014-03-06T13:09:30Z,,0,0,09000064815fd1b2